Disease Prediction using Graph Convolutional Networks: Application to Autism Spectrum Disorder and Alzheimer's Disease
Aimbrain Solutions ltd(艾姆布莱恩解决方案有限公司);Imperial College London(帝国理工学院);Research Institute for Signals, Systems and Computational Intelligence, sinc(i), FICH-UNL/CONICET(信号、系统与计算智能研究所(sinc(i)),国立罗萨里奥大学计算与人文学院/阿根廷国家科学与技术研究理事会);StoryStream Ltd.(故事流有限公司)
Sarah Parisot, Sofia Ira Ktena, Enzo Ferrante, Matthew Lee, Ricardo Guerrero, Ben Glocker, Daniel Rueckert
备注:
in Press at Medical Image Analysis, MICCAI 2017 Special Issue
Graphs are widely used as a natural framework that captures interactions between individual elements represented as nodes in a graph. In medical applications, specifically, nodes can represent individuals within a potentially large population (patients or healthy controls) accompanied by a set of features, while the graph edges incorporate associations between subjects in an intuitive manner. This representation allows to incorporate the wealth of imaging and non-imaging information as well as individual subject features simultaneously in disease classification tasks. Previous graph-based approaches for supervised or unsupervised learning in the context of disease prediction solely focus on pairwise similarities between subjects, disregarding individual characteristics and features, or rather rely on subject-specific imaging feature vectors and fail to model interactions between them. In this paper, we present a thorough evaluation of a generic framework that leverages both imaging and non-imaging information and can be used for brain analysis in large populations. This framework exploits Graph Convolutional Networks (GCNs) and involves representing populations as a sparse graph, where its nodes are associated with imaging-based feature vectors, while phenotypic information is integrated as edge weights. The extensive evaluation explores the effect of each individual component of this framework on disease prediction performance and further compares it to different baselines. The framework performance is tested on two large datasets with diverse underlying data, ABIDE and ADNI, for the prediction of Autism Spectrum Disorder and conversion to Alzheimer's disease, respectively. Our analysis shows that our novel framework can improve over state-of-the-art results on both databases, with 70.4% classification accuracy for ABIDE and 80.0% for ADNI.
Prediction of Progression to Alzheimer's disease with Deep InfoMax
The Mind Research Network(心智研究网络);University of New Mexico(新墨西哥大学);Microsoft Research(微软研究院);Montreal Institute for Learning Algorithms(蒙特利尔学习算法研究所);University of Montreal(蒙特利尔大学);Shanxi University(山西大学)
Deep Learning Approaches with Explainable AI for Differentiating Alzheimer Disease and Mild Cognitive Impairment
School of Mathematical and Natural Sciences(数学与自然科学学院);Arizona State University(亚利桑那州立大学);Department of Mathematics(数学系);Florida Gulf Coast University(佛罗里达海岸大学);Department of Public Health(公共卫生系);Julia Jones Matthews School of Population and Public Health(朱莉亚·琼斯·马修斯人口与公共卫生学院);Texas Tech University Health Sciences Center(德克萨斯农工大学健康科学中心)